Profile data is unavailable for this security.
About the company
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
- Revenue in USD (TTM)0.00
- Net income in USD-6.50m
- Incorporated2003
- Employees31.00
- LocationScinai Immunotherapeutics LtdJerusalem Biopark2Nd Floor, Hadassah Ein Kerem CampusJERUSALEM 00000IsraelISR
- Phone+972 89302529
- Fax+972 89302531
- Websitehttps://www.scinai.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics Inc | 0.00 | -12.48m | 1.81m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
| Target Group Inc | 5.64m | 228.87k | 1.82m | 46.00 | 22.69 | -- | 1.71 | 0.3227 | 0.0001 | 0.0001 | 0.0088 | -0.0115 | 0.764 | 8.60 | 124.27 | 115,104.10 | 3.10 | -37.99 | -- | -78.76 | 43.71 | -- | 4.06 | -586.97 | 0.0736 | 0.0149 | 3.10 | -- | -- | 577.83 | 92.84 | -- | -58.54 | -- |
| SYBLEU Inc | 11.70k | -307.88k | 1.84m | -- | -- | -- | -- | 157.17 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
| Link Reservations Inc | 0.00 | -480.90k | 1.85m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
| PainReform Ltd | 0.00 | -12.54m | 1.86m | 6.00 | -- | 0.7509 | -- | -- | -7.77 | -7.77 | 0.00 | 0.9988 | 0.00 | -- | -- | 0.00 | -158.88 | -55.47 | -222.89 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
| Applied DNA Sciences Inc | 5.52m | -12.50m | 1.92m | 53.00 | -- | -- | -- | 0.3477 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| SOHM Inc | -100.00bn | -100.00bn | 1.92m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CanaQuest Medical Corp | 0.00 | -804.12k | 1.92m | -- | -- | -- | -- | -- | -0.0512 | -0.0512 | 0.00 | -0.0369 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
| Twinlab Consolidated Holdings Inc | 12.65m | -9.55m | 1.94m | 17.00 | -- | -- | -- | 0.1537 | -0.0369 | -0.0502 | 0.0488 | -0.5447 | 1.01 | 1.49 | 7.30 | 743,941.20 | -76.13 | -60.53 | -- | -- | 34.59 | 21.36 | -75.51 | -37.72 | 0.0094 | -0.0108 | -- | -- | -20.87 | -28.58 | -20.28 | -- | -- | -- |
| CYANOTECH CORP | 22.49m | -4.62m | 1.98m | 86.00 | -- | 0.1419 | -- | 0.088 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
| Scinai Immunotherapeutics Ltd - ADR | 0.00 | -6.50m | 2.00m | 31.00 | -- | -- | -- | -- | -2.31 | -2.31 | 0.00 | -0.9841 | -- | -- | -- | 0.00 | -- | -42.48 | -- | -57.00 | -- | -- | -- | -- | -- | -- | 1.31 | -- | -- | -- | -12.15 | -- | -37.36 | -- |
| Virax Biolabs Group Ltd | 0.00 | -1.71m | 2.02m | 5.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.8568 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.0223 | -112.29 | -- | -- | -100.00 | -- | -162.50 | -- | -- | -- |
| Lucy Scientific Discovery Inc | 16.73k | -9.76m | 2.15m | -- | -- | 26.53 | -- | 128.69 | -6.34 | -7.21 | 0.0103 | 0.046 | 0.0037 | -- | 0.7276 | -- | -215.45 | -- | -- | -- | 49.97 | -- | -58,360.55 | -- | -- | -5.10 | 0.4615 | -- | -- | -- | -53.49 | -- | -- | -- |
| Panbela Therapeutics Inc | 0.00 | -27.26m | 2.18m | 7.00 | -- | -- | -- | -- | -20.38 | -20.38 | 0.00 | -0.6563 | 0.00 | -- | -- | 0.00 | -201.94 | -215.89 | -809.38 | -476.38 | -- | -- | -- | -- | -- | -161.79 | 4.16 | -- | -- | -- | 27.68 | -- | -- | -- |
Data as of May 23 2024. Currency figures normalised to Scinai Immunotherapeutics Ltd's reporting currency: US Dollar USD
